CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Grant or award Director acquired 10,139 shares (grant or award)
- 4 Open-market sale Director sold 10,000 shares at an average $8.01 ($80,092)
- 4 Open-market sale Burnett Patrick sold 72,952 shares at an average $8.73 ($636,706)
- 4 Planned sale Matsuda Masaru sold 1,775 shares at $9.01 ($15,988)
- 4 Open-market sale SVP Chief Commercial Officer sold 7,640 shares at $8.98 ($68,582)
- 4 Planned sale SVP and Chief Business Officer sold 4,681 shares at $8.74 ($40,902)
- 4 Planned sale Watanabe Todd Franklin sold 13,783 shares at $8.74 ($120,433)
- 4 Planned sale Matsuda Masaru sold 5,016 shares at $8.74 ($43,829)
- 4 Planned sale Burnett Patrick sold 9,555 shares at $8.74 ($83,490)
- 4 Grant or award Chief Financial Officer acquired 110,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Matsuda Masaru sold 3,760 shares at $11.12 ($41,816)
- 4 Planned sale Burnett Patrick sold 4,782 shares at $11.12 ($53,182)
- 4 Planned sale Watanabe Todd Franklin sold 14,903 shares at $11.12 ($165,739)
Page 9 of 23 · 452 filings